Leerink Swann Starts Rigel Pharmaceuticals (RIGL) at Outperform; Top Biotech with Two Drivers
Tweet Send to a Friend
Leerink Swann initiates coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with an Outperform. PT $16.00.
Analyst, Irene Lau, said, "RIGL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Irene Lau, said, "RIGL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
